Best Practices, LLC Home
View Cart Search the Site Contact Best Practices, LLC Press Room of Best Practices, LLC
ABOUT US RESEARCH & CONSULTING BENCHMARKING REPORTS BEST PRACTICE DATABASE RESEARCH & ADVISORY SERVICES BEST PRACTICES EXCELLENCE SERVICES
Advanced Search
Wizards and Analytics Search
Simple Search
By Subject Area
Sales and Marketing > Strategic Alliances > Identifying and Evaluating Potential Products > Identifying Potential Products
Identifying Potential Products Research

Pharma-Biotech Alliance Management Success: Deal Evaluation and Negotiation 
Non-members: Click here to sign-up for a complimentary tour of "Pharma-Biotech Alliance Management Success: Deal Evaluation and Negotiation" Study Overview To prosper, pharmaceutical and biotechnology companies must forge strong development and marketing alliances... (ID 4770)
Companies Profiled: Atrix, AtheroGenics, Bristol-Myers Squibb, CV Therapeutics, more ...
Price: $1562.00
Pharma & Biotech Co-Promotion Alliance and Relationship Management 
Non-members: Click here to sign-up for a complimentary tour of "Pharma & Biotech Co-Promotion Alliance and Relationship Management" Study Overview The success of any co-development deal or co-promotion deal hinges on stellar alliance execution and careful relationship management... (ID 4769)
Companies Profiled: Atrix, AtheroGenics, Bristol-Myers Squibb, CV Therapeutics, more ...
Price: $1184.00
Identifying and Evaluating Potential Products in Driving Growth through New Product Planning and Strategic Alliances 
Study Overview Knowing how to most effectively identify and evaluate potential products and how to establish decision goals for products to ensure efficiency and accountability is a necessity for any pharmaceutical company... (ID 4681)
Companies Profiled: Eli Lilly, Pfizer, Amgen, Janssen
Price: $1348.95
Structuring New Product Planning and Strategic Alliance Teams 
Study Overview New product planning and strategic alliance teams are important for the overall health of the company... (ID 4677)
Companies Profiled: Eli Lilly, Pfizer, Amgen, Janssen
Price: $669.95
Pharmaceutical & Diagnostic Companies: Best Practices in Partnerships & Strategic Alliances 
This 11-page document discusses the factors that contribute to a healthy and thriving partnership or alliance between pharmaceutical and diagnostic companies... (ID 4362)
Companies Profiled: Eli Lilly, bioMerieux, Visible Genetics, LipoScience, more ...
Price: $834.95
Can Pharmaceutical & Diagnostic Companies Work Together?: Case Studies 
This 9-page document describes two partnerships between a pharmaceutical and diagnostic companies... (ID 4358)
Companies Profiled: Merck
Price: $568.95
Developing a Diagnostic Test: The Pharmaceutical Industry Perspective 
This 6-page document summarizes the key factors that guide pharmaceutical companies' thinking on pairing therapeutics with diagnostic tests... (ID 4357)
Companies Profiled: Eli Lilly, bioMerieux, Visible Genetics, LipoScience, more ...
Price: $568.95
Can Pharmaceutical & Diagnostic Companies Work Together?: Developing and Preparing A Diagnostic Test 
This 22-page document discusses the critical factors that determine when a diagnostic company will move forward with the development of a diagnostic test, including technical feasability... (ID 4350)
Companies Profiled: Eli Lilly, bioMerieux, Visible Genetics, LipoScience, more ...
Price: $834.95

 


All contents copyright © 1999-2012 Best Practices, LLC 6350 Quadrangle Drive, Chapel Hill, NC 27517 USA (919) 403-0251.
Site Map | Please see our Terms and Conditions of Use and Privacy Policy.

This site is optimized for 4.0 and higher versions of Microsoft Internet Explorer and Netscape Navigator.
If you experience difficulties using our e-commerce system, please check your browser version and our FAQs.